ELVN
Enliven Therapeutics Inc.
45.20$
-2.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | – | – | +193.9% | +2.1% | +528.3% | -52.3% | +6.7% | -17.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | +4.1% | +130.7% | -56.7% | +148.5% | +51.5% | +108.2% | +25.1% | +6.3% | |
| – | – | +109.5% | -78.9% | +297.8% | +81.2% | +144.0% | +25.4% | +42.2% | |
| – | +19.9% | +125.6% | -61.3% | +165.7% | +56.7% | +115.3% | +25.2% | +14.2% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +1,208.6% | – | – | – | |
| – | -5,229.9% | – | – | – | – | – | – | – | |
| – | -471.5% | – | -104.7% | – | – | +1,377.3% | -82.2% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | -5,229.9% | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.